Selected research
Market Analysis & Forecast
Global Ranitidine Market Analysis and Forecast 2026-2032
Market perspective
The global Ranitidine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Ranitidine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Ranitidine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Ranitidine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Ranitidine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Ranitidine include GSK, Sun Pharma, Merck, Tocris Bioscience (R & D Systems), Strides Pharma Science Limited (Strides Shasun) and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Ranitidine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Ranitidine, also provides the sales of main regions and countries. Of the upcoming market potential for Ranitidine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ranitidine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ranitidine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ranitidine sales, projected growth trends, production technology, application and end-user industry.
Ranitidine Segment by Company
GSK
Sun Pharma
Merck
Tocris Bioscience (R & D Systems)
Strides Pharma Science Limited (Strides Shasun)
Boehringer Ingelheim
Ranitidine Segment by Type
Tablet
Syrup
Injection
Ranitidine Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Ranitidine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ranitidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ranitidine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ranitidine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Ranitidine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Ranitidine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ranitidine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Syrup
- Injection
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- GSK
- Sun Pharma
- Merck
- Tocris Bioscience (R & D Systems)
- Strides Pharma Science Limited (Strides Shasun)
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Ranitidine Market by Type
- 1.2.1 Global Ranitidine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Tablet
- 1.2.3 Syrup
- 1.2.4 Injection
- 1.3 Ranitidine Market by Application
- 1.3.1 Global Ranitidine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Retail Pharmacies
- 1.3.3 Online Pharmacies
- 1.3.4 Hospital Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Ranitidine Market Dynamics
- 2.1 Ranitidine Industry Trends
- 2.2 Ranitidine Industry Drivers
- 2.3 Ranitidine Industry Opportunities and Challenges
- 2.4 Ranitidine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Ranitidine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Ranitidine Revenue by Region
- 3.2.1 Global Ranitidine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Ranitidine Revenue by Region (2021-2026)
- 3.2.3 Global Ranitidine Revenue by Region (2027-2032)
- 3.2.4 Global Ranitidine Revenue Market Share by Region (2021-2032)
- 3.3 Global Ranitidine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Ranitidine Sales by Region
- 3.4.1 Global Ranitidine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Ranitidine Sales by Region (2021-2026)
- 3.4.3 Global Ranitidine Sales by Region (2027-2032)
- 3.4.4 Global Ranitidine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Ranitidine Revenue by Manufacturers
- 4.1.1 Global Ranitidine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Ranitidine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Ranitidine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Ranitidine Sales by Manufacturers
- 4.2.1 Global Ranitidine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Ranitidine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Ranitidine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Ranitidine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Ranitidine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Ranitidine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Ranitidine Manufacturers, Product Type & Application
- 4.7 Global Ranitidine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Ranitidine Market CR5 and HHI
- 4.8.2 2025 Ranitidine Tier 1, Tier 2, and Tier 3
5 Ranitidine Market by Type
- 5.1 Global Ranitidine Revenue by Type
- 5.1.1 Global Ranitidine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Ranitidine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Ranitidine Revenue Market Share by Type (2021-2032)
- 5.2 Global Ranitidine Sales by Type
- 5.2.1 Global Ranitidine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Ranitidine Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Ranitidine Sales Market Share by Type (2021-2032)
- 5.3 Global Ranitidine Price by Type
6 Ranitidine Market by Application
- 6.1 Global Ranitidine Revenue by Application
- 6.1.1 Global Ranitidine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Ranitidine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Ranitidine Revenue Market Share by Application (2021-2032)
- 6.2 Global Ranitidine Sales by Application
- 6.2.1 Global Ranitidine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Ranitidine Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Ranitidine Sales Market Share by Application (2021-2032)
- 6.3 Global Ranitidine Price by Application
7 Company Profiles
- 7.1 GSK
- 7.1.1 GSK Company Information
- 7.1.2 GSK Business Overview
- 7.1.3 GSK Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 GSK Ranitidine Product Portfolio
- 7.1.5 GSK Recent Developments
- 7.2 Sun Pharma
- 7.2.1 Sun Pharma Company Information
- 7.2.2 Sun Pharma Business Overview
- 7.2.3 Sun Pharma Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sun Pharma Ranitidine Product Portfolio
- 7.2.5 Sun Pharma Recent Developments
- 7.3 Merck
- 7.3.1 Merck Company Information
- 7.3.2 Merck Business Overview
- 7.3.3 Merck Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Merck Ranitidine Product Portfolio
- 7.3.5 Merck Recent Developments
- 7.4 Tocris Bioscience (R & D Systems)
- 7.4.1 Tocris Bioscience (R & D Systems) Company Information
- 7.4.2 Tocris Bioscience (R & D Systems) Business Overview
- 7.4.3 Tocris Bioscience (R & D Systems) Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Tocris Bioscience (R & D Systems) Ranitidine Product Portfolio
- 7.4.5 Tocris Bioscience (R & D Systems) Recent Developments
- 7.5 Strides Pharma Science Limited (Strides Shasun)
- 7.5.1 Strides Pharma Science Limited (Strides Shasun) Company Information
- 7.5.2 Strides Pharma Science Limited (Strides Shasun) Business Overview
- 7.5.3 Strides Pharma Science Limited (Strides Shasun) Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Strides Pharma Science Limited (Strides Shasun) Ranitidine Product Portfolio
- 7.5.5 Strides Pharma Science Limited (Strides Shasun) Recent Developments
- 7.6 Boehringer Ingelheim
- 7.6.1 Boehringer Ingelheim Company Information
- 7.6.2 Boehringer Ingelheim Business Overview
- 7.6.3 Boehringer Ingelheim Ranitidine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Boehringer Ingelheim Ranitidine Product Portfolio
- 7.6.5 Boehringer Ingelheim Recent Developments
8 North America
- 8.1 North America Ranitidine Market Size by Type
- 8.1.1 North America Ranitidine Revenue by Type (2021-2032)
- 8.1.2 North America Ranitidine Sales by Type (2021-2032)
- 8.1.3 North America Ranitidine Price by Type (2021-2032)
- 8.2 North America Ranitidine Market Size by Application
- 8.2.1 North America Ranitidine Revenue by Application (2021-2032)
- 8.2.2 North America Ranitidine Sales by Application (2021-2032)
- 8.2.3 North America Ranitidine Price by Application (2021-2032)
- 8.3 North America Ranitidine Market Size by Country
- 8.3.1 North America Ranitidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Ranitidine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Ranitidine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Ranitidine Market Size by Type
- 9.1.1 Europe Ranitidine Revenue by Type (2021-2032)
- 9.1.2 Europe Ranitidine Sales by Type (2021-2032)
- 9.1.3 Europe Ranitidine Price by Type (2021-2032)
- 9.2 Europe Ranitidine Market Size by Application
- 9.2.1 Europe Ranitidine Revenue by Application (2021-2032)
- 9.2.2 Europe Ranitidine Sales by Application (2021-2032)
- 9.2.3 Europe Ranitidine Price by Application (2021-2032)
- 9.3 Europe Ranitidine Market Size by Country
- 9.3.1 Europe Ranitidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Ranitidine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Ranitidine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Ranitidine Market Size by Type
- 10.1.1 China Ranitidine Revenue by Type (2021-2032)
- 10.1.2 China Ranitidine Sales by Type (2021-2032)
- 10.1.3 China Ranitidine Price by Type (2021-2032)
- 10.2 China Ranitidine Market Size by Application
- 10.2.1 China Ranitidine Revenue by Application (2021-2032)
- 10.2.2 China Ranitidine Sales by Application (2021-2032)
- 10.2.3 China Ranitidine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Ranitidine Market Size by Type
- 11.1.1 Asia Ranitidine Revenue by Type (2021-2032)
- 11.1.2 Asia Ranitidine Sales by Type (2021-2032)
- 11.1.3 Asia Ranitidine Price by Type (2021-2032)
- 11.2 Asia Ranitidine Market Size by Application
- 11.2.1 Asia Ranitidine Revenue by Application (2021-2032)
- 11.2.2 Asia Ranitidine Sales by Application (2021-2032)
- 11.2.3 Asia Ranitidine Price by Application (2021-2032)
- 11.3 Asia Ranitidine Market Size by Country
- 11.3.1 Asia Ranitidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Ranitidine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Ranitidine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Ranitidine Market Size by Type
- 12.1.1 SAMEA Ranitidine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Ranitidine Sales by Type (2021-2032)
- 12.1.3 SAMEA Ranitidine Price by Type (2021-2032)
- 12.2 SAMEA Ranitidine Market Size by Application
- 12.2.1 SAMEA Ranitidine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Ranitidine Sales by Application (2021-2032)
- 12.2.3 SAMEA Ranitidine Price by Application (2021-2032)
- 12.3 SAMEA Ranitidine Market Size by Country
- 12.3.1 SAMEA Ranitidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Ranitidine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Ranitidine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Ranitidine Value Chain Analysis
- 13.1.1 Ranitidine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Ranitidine Production Mode & Process
- 13.2 Ranitidine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Ranitidine Distributors
- 13.2.3 Ranitidine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst